Skip to content

Effect of dexmedetomidine nasal spray on postoperative delirium in elderly patients undergoing hip and knee replacement: a randomized controlled trial

Effect of dexmedetomidine nasal spray on postoperative delirium in elderly patients undergoing hip and knee replacement: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101130
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-25
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Intravenous group:Nasal spray of normal saline was used before operation, and dexmedetomidine was pumped during operation
Nasal spray group:Dexmedetomidine was nasal sprayed before operation, and normal saline was pumped during operation
Control group:Normal saline was nasal sprayed before operation and pumped during operation

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elderly patients aged >=65 years; 2. Elderly patients undergoing elective hip replacement or knee replacement under combined spinal-epidural block; 3. The expected length of hospital stay should be at least 3 days; 4. The American Society of Anesthesiologists (ASA) score was grade II-III;

Exclusion criteria

Exclusion criteria: 1. Patients with preoperative cognitive impairment or previous history of cognitive impairment, dementia, and delirium; 2. Patients with preoperative sick sinus syndrome, severe bradycardia (heart rate <50 beats/min) or atrioventricular block of second degree or above, permanent pacemaker implantation, severe heart failure or ejection fraction <30%; 3. Patients with rhinitis who are not suitable to use nasal spray; 4. Allergic to dexmedetomidine nasal spray or other anesthetic drugs used in this study; 5. Patients who withdraw or die due to uncooperative or unexpected circumstances;

Design outcomes

Primary

MeasureTime frame
the severity of delirium;postoperative delirium;

Secondary

MeasureTime frame
Level of sedation;Severity of cognitive impairment;Quality of Recovery Questionnaire (QoR-15 score);Level of anxiety;

Countries

China

Contacts

Public ContactLi Jianli

Hebei General Hospital

hblijianli@163.com+86 311 85988447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026